Revenue segments as reported by the company.

Electronics & Industrial

Water & Protection

Corporate & Other

Mobility & Materials

Corporate

Electronics & Imaging

Nutrition & Biosciences

Transportation & Industrial

Safety & Construction

Non-Core

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development expenses

Selling, general and administrative expenses

Amortization of intangibles

Restructuring and asset related charges - net

Goodwill impairment charges

Acquisition, integration and separation costs

Equity in earnings of nonconsolidated affiliates

Sundry income (expense) - net

Interest expense

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

DuPont de Nemours

Danisco is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar (founded 1872), and Dansk Handels- og Industri Company (Danisco A/S).

Danisco

Solae was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco. The company developed food, feed and industrial ingredients, focusing on soy. Many of the studies supporting the Food and Drug Administration-approved health claim were based on research using Solae soy protein.

Solae

DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics and Industrial, Water and Protection, and Corporate and Others. The Electronics and Industrial segment involves the supply of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The Water and Protection segment focuses on the provision of engineered products and integrated systems for many industries including worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The company was founded in 1897 and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DuPont reports strong Q4 results, eyes growth amid challenges

DuPont's Q4 performance showcased organic revenue growth and margin improvement, supported by strategic actions and portfolio transformation.
While facing challenges in the shelter business and market conditions, DuPont remains focused on innovation, growth opportunities, and shareholder value enhancement.
The company's outlook for 2023 includes solid top-line growth, operational targets, and a strategic focus on managing challenges and leveraging growth opportunities.

DuPont exceeds Q1 expectations, eyes healthcare growth amid market challenges

DuPont's Q1 performance was solid, with revenue and adjusted EPS surpassing guidance, driven by acquisitions and ongoing market strengths. Challenges in the electronics market and inventory destocking impacted full-year guidance, but opportunities for growth in healthcare and other sectors are on the horizon. The company's focus on sustainability and operational efficiency remains key.

DuPont reports resilient Q2 performance amidst market challenges

DuPont's Q2 performance showed resilience amid market challenges, with a focus on strategic priorities for long-term growth.
While facing volume pressures and market uncertainties, DuPont is leveraging acquisitions and cost controls to drive value.
Opportunities lie in sequential business improvements, cost reductions, and sustainability-focused sales strategies.
Challenges include market-specific declines and regional growth variations that require strategic adjustments.

DuPont reports solid Q3 earnings amidst China challenges and growth opportunities

DuPont's Q3 performance showcased resilience amid challenges, with revenue declines offset by improved margins and EPS growth. Strategic acquisitions and divestitures are driving the company forward.
Despite facing headwinds in China and inventory destocking, DuPont is capitalizing on opportunities in semiconductors and other key segments. Efforts to enhance efficiency and target growth areas position the company for future success.
While challenges like trade restrictions and industrial destocking persist, DuPont remains focused on leveraging growth opportunities in AI, electronics, and other segments. Maintaining a strong cash position and returning value to shareholders are key priorities.

DuPont reports Q4 2023 results, eyes growth in key markets

DuPont's Q4 performance saw declines in net sales and EBITDA, but the company remains resilient amidst market challenges. Cost-saving initiatives and share repurchase programs demonstrate strategic financial management.
Despite absorption headwinds and challenges in China, DuPont's focus on key markets like semiconductors and water positions it for growth. The company's long-term EBITDA margin outlook is positive.
Opportunities in market stabilization, recovery in key sectors, and potential growth in water and electronics segments offer DuPont avenues for future expansion and profitability.

DuPont surpasses Q1 expectations, eyes growth amid market challenges

DuPont's Q1 2024 performance exceeded expectations, prompting an upward revision of full-year guidance across key financial metrics.
The company's focus on operational excellence, sustainability, and market diversification positions it well for recovery and growth in 2024 and beyond.
While facing challenges in pricing and market dynamics, DuPont's strategic initiatives and opportunities in key segments offer avenues for future growth.
Overall, DuPont's strong performance, prudent risk management, and focus on innovation and efficiency underscore its resilience and potential for sustained success.

DuPont surpasses Q2 expectations, eyes growth in tech and China

DuPont delivered strong Q2 2024 results, exceeding guidance and showcasing resilience across key segments.
Strategic initiatives like the Donatelle acquisition and planned separation activities position DuPont for future growth and market leadership.
While legal challenges persist, DuPont's proactive approach and focus on innovation and diversification bode well for long-term success.

DuPont reports strong Q3 earnings and progresses on strategic separations

DuPont's Q3 earnings call reflects a robust performance with growth in key financial metrics and segments. The company's focus on operational excellence and strategic initiatives has positioned it for continued success. While challenges exist, DuPont's ability to capitalize on opportunities and drive innovation bodes well for future growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Boeing

Caterpillar

Ford Motor Company

General Electric

United Technologies

United States Steel

Exxon Mobil

Colgate-Palmolive

Coca-Cola

PepsiCo

Procter & Gamble

10 Stocks For 40 Years

Apple

Amazon

General Motors

Alphabet

Microsoft

Philip Morris

AT&T

Walmart

There were a lot of changes on Wall Street in the 2010s. One thing that changed in the decade was the title of world’s most valuable company.

12 Stocks That Have Been The World's Most Valuable Company

Cabot Oil & Gas

Exelon

Tuesday's big stock charts focus on struggling names hoping to catch a bid in the new year.
The post 3 Big Stock Charts for Tuesday: DuPont, Exelon, and Cabot Oil & Gas appeared first on InvestorPlace.

3 Big Stock Charts for Tuesday: DuPont, Exelon, and Cabot Oil & Gas

DuPont: Pouring The Cocktail

A challenging global economic scenario and soft end-market demand due to the trade war have kept DuPont's (DD) stock under pressure.

Will DuPont (DD) Witness Turbulence in the Next Year Too?

DuPont: The Path Is Becoming Clearer

CVS Health

General Dynamics

Texas Instruments

The S&P Dow Jones Indices must be more proactive to protect investors from getting confused.

Remove Boeing, Walgreens, Dow And UTD From The DJIA And Replace Them With These 4 Stocks

Here's why you should have more faith in DuPont analysis than simple ROE calculation and bet on these five stocks.

4 DuPont-Driven Top-Ranked Stocks for Quality Investing

DuPont's (DD) MEMCOR MBR product and MABR technology offer more solutions for customers seeking to reduce footprint and energy requirements for secondary wastewater treatment.

DuPont Exercises Option to Acquire 100% Ownership of OxyMem

Anthem

GoDaddy

G-III Apparel Group

Norwegian Cruise Line

Royal Caribbean Cruises

CNBC combed through recent Wall Street research to find stocks that top analysts say are "undervalued." Among them, Dupont, GoDaddy, and Royal Caribbean.

Wall Street analysts say these stocks are 'undervalued' heading into 2020

ABIOMED

A. O. Smith

Dell Technologies

Foot Locker

Hess

Kohl's

MasTec

PagSeguro Digital

Rollins

2019 has been one of the best years for stocks in recent memory. Heading into 2020, here are 10 stocks to buy that are struggling to finish well.

10 Stocks to Buy That Lost 8%-Plus in the Past Month

International Flavors & Fragrances

International Flavors & Fragrances is merging with DuPont's nutrition and biosciences unit, creating a $45.4 billion consumer goods giant.

DuPont chairman says deal with IFF gives new company 'double the R&D' of competitors

International Flavors' (IFF) merger deal to create a leading company in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets.

International Flavors (IFF) Seals Merger Deal With DuPont Arm

International Flavors & Fragrances on Sunday said it will merge with DuPont's $26.2 billion nutrition & biosciences unit, in a deal that will create a new combined company.

IFF to merge with DuPont's $26.2 billion nutrition unit.

DuPont is creating a new $45.4 billion consumer goods giant by merging its food and nutrition business with International Flavors & Fragrances.

A deal for DuPont's food business will create a $45 billion giant

International Flavors & Fragrances Inc  on Sunday said it will merge with DuPont Inc's  $26.2 billion nutrition & biosciences unit, in a deal that will create a new combined company.

IFF to merge with DuPont's $26.2 billion nutrition unit

Use the DuPont technique to pick solid profit-generating stocks.

5 Winning Stocks Screened Though DuPont Technique

The buyout reinforces DuPont's (DD) portfolio with a compelling offering to further minimize the lifecycle cost of water purification and reuse.

DuPont (DD) Scoops Up Desalitech, Strengthens Portfolio

Centene

Delta Air Lines

Hewlett Packard

LyondellBasell Industries

Rio Tinto plc Sponsored

United Continental Hlds

UnitedHealth Group

Even as the market soars to new record highs, these stocks still have significant upside potential, per research by Bernstein.

10 Bargain Blue Chips with Improving Growth Prospects

News for DuPont de Nemours Stock (DD)